Literature DB >> 15053006

Strategies for using in vitro screens in drug metabolism.

Nick Plant1.   

Abstract

In vitro assays are increasingly being used in drug metabolism studies to screen novel chemicals. Their advantages are twofold: first, they allow testing early in the drug discovery phase, providing important information on chemical characteristics; second, human cells or cell constituents can be utilized, increasing the relevance to man. However, the process of isolation, transformation or storage of these cell systems may alter their phenotype (and, in the case of tumour-derived cell lines, genotype as well). A review of the systems currently employed shows that, whereas all systems have their own caveats, it is possible to find an appropriate system for any particular question that is asked.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053006     DOI: 10.1016/s1359-6446(03)03019-8

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  14 in total

1.  Comparative Proteomics Analysis of Human Liver Microsomes and S9 Fractions.

Authors:  Xinwen Wang; Bing He; Jian Shi; Qian Li; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2019-11-07       Impact factor: 3.922

2.  Evaluation of geno-toxicity of methyl parathion and chlorpyrifos to human liver carcinoma cell line (HepG2).

Authors:  Rajashree Patnaik; Rabindra Nath Padhy
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-19       Impact factor: 4.223

3.  A Cyclic Phosphoramidate Prodrug of 2'-Deoxy-2'-Fluoro-2'-C-Methylguanosine for the Treatment of Dengue Virus Infection.

Authors:  Ratna Karuna; Fumiaki Yokokawa; Keshi Wang; Jin Zhang; Haoying Xu; Gang Wang; Mei Ding; Wai Ling Chan; Nahdiyah Abdul Ghafar; Andrea Leonardi; Cheah Chen Seh; Peck Gee Seah; Wei Liu; Rao P S Srinivasa; Siew Pheng Lim; Suresh B Lakshminarayana; Ellie Growcott; Sreehari Babu; Martijn Fenaux; Weidong Zhong; Feng Gu; Pei-Yong Shi; Francesca Blasco; Yen-Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

4.  Bovine liver slices combined with an androgen transcriptional activation assay: an in-vitro model to study the metabolism and bioactivity of steroids.

Authors:  S Wang; J C W Rijk; J H Riethoff-Poortman; S Van Kuijk; A A C M Peijnenburg; T F H Bovee
Journal:  Anal Bioanal Chem       Date:  2010-03-17       Impact factor: 4.142

5.  Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures.

Authors:  C Shen; Q Meng; G Zhang; W Hu
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

6.  Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assays.

Authors:  Samantha Forster; Alfred E Thumser; Steve R Hood; Nick Plant
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

7.  Prediction of overall in vitro microsomal stability of drug candidates based on molecular modeling and support vector machines. Case study of novel arylpiperazines derivatives.

Authors:  Szymon Ulenberg; Mariusz Belka; Marek Król; Franciszek Herold; Weronika Hewelt-Belka; Agata Kot-Wasik; Tomasz Bączek
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

8.  Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability.

Authors:  Samantha J Richardson; April Bai; Ashutosh A Kulkarni; Mehran F Moghaddam
Journal:  Drug Metab Lett       Date:  2016

9.  The effects of selected Australian snake venoms on tumour-associated microvascular endothelial cells (TAMECs) in vitro.

Authors:  Emma Bateman; Michael Venning; Peter Mirtschin; Anthony Woods
Journal:  J Venom Res       Date:  2013-10-19

10.  In-vivo absorption of pinocembrin-7-O-β-D-glucoside in rats and its in-vitro biotransformation.

Authors:  Wei-Wei Guo; Feng Qiu; Xiao-Qing Chen; Yin-Ying Ba; Xing Wang; Xia Wu
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.